Balance Sheet
Cash Flow Statement
AmortizationAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Change in Intangibles (2020 - 2023)

Historic Change in Intangibles for Legend Biotech (LEGN) over the last 4 years, with Q3 2023 value amounting to -$96000.0.

  • Legend Biotech's Change in Intangibles fell 11051.48% to -$96000.0 in Q3 2023 from the same period last year, while for Sep 2024 it was -$96000.0, marking a year-over-year increase of 9352.23%. This contributed to the annual value of -$1.3 million for FY2022, which is 5796.69% up from last year.
  • Legend Biotech's Change in Intangibles amounted to -$96000.0 in Q3 2023, which was down 11051.48% from -$348000.0 recorded in Q2 2023.
  • Over the past 5 years, Legend Biotech's Change in Intangibles peaked at $913000.0 during Q3 2022, and registered a low of -$4.0 million during Q4 2020.
  • Its 4-year average for Change in Intangibles is -$987076.9, with a median of -$654000.0 in 2021.
  • As far as peak fluctuations go, Legend Biotech's Change in Intangibles plummeted by 52833.33% in 2021, and later soared by 18072.5% in 2022.
  • Legend Biotech's Change in Intangibles (Quarter) stood at -$4.0 million in 2020, then grew by 20.4% to -$3.2 million in 2021, then surged by 57.97% to -$1.3 million in 2022, then skyrocketed by 92.88% to -$96000.0 in 2023.
  • Its Change in Intangibles was -$96000.0 in Q3 2023, compared to -$348000.0 in Q2 2023 and $310000.0 in Q1 2023.